This is an archived page. Images and links on this page may not work. Please visit the main page for the latest updates.

 
 
 
Read my book, TEACHING BEAUTY IN DeLILLO, WOOLF, AND MERRILL (Palgrave Macmillan; forthcoming), co-authored with Jennifer Green-Lewis. VISIT MY BRANCH CAMPUS AT INSIDE HIGHER ED





UD is...
"Salty." (Scott McLemee)
"Unvarnished." (Phi Beta Cons)
"Splendidly splenetic." (Culture Industry)
"Except for University Diaries, most academic blogs are tedious."
(Rate Your Students)
"I think of Soltan as the Maureen Dowd of the blogosphere,
except that Maureen Dowd is kind of a wrecking ball of a writer,
and Soltan isn't. For the life of me, I can't figure out her
politics, but she's pretty fabulous, so who gives a damn?"
(Tenured Radical)

Wednesday, July 19, 2006

Tons of These Cases...

...lately. So many I've not blogged most of them. It'd be more like flogging than blogging.

Greed's the cause, questionable results the effect. Universities, and journals, proceed at their risk.


'Days after announcing a crackdown on researchers who do not disclose drug company ties, the editor of The Journal of the American Medical Association said she was misled again, this time by the authors of a study linking severe migraines to heart attacks in women.

All six authors of the study have done consulting work or received research financing from makers of treatments for migraines or heart-related problems. Their research appears in Wednesday’s journal.

The authors said they did not report their financial ties because they did not believe they were relevant to the study. The editor, Dr. Catherine D. DeAngelis, said she would have published the authors’ associations with drug makers had she known about them.

The journal posted a letter online Tuesday from the authors explaining the omissions, Dr. DeAngelis’s response and a correction.

Last week, the journal disclosed that the authors of a depression study failed to report ties to makers of antidepressants. And two months ago, it reported similar omissions from authors of a study linking certain arthritis drugs to cancer.'